Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $558.3800 (1.73%) ($545.2042 - $559.1800) on Mon. Nov. 16, 2015. | |
| | Trend Analysis and Forecast | | | | Average Daily Percentage Swing | 2.86% (three month average) | | RSI | 46 | | Latest Price | $558.3800(1.73%) | | Stocks Behave Similarly | Similar Stock List | | Weekly Trend | REGN declines -0.8% a week on average for past two weeks. | | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability)
IBB(64%) XLV(51%) XBI(49%) QQQ(42%) IVW(41%) | | Factors Impacting REGN price | REGN will decline at least -1.43% in a week (0% probabilities).
VIXM(-14%) TLT(-9%) UUP(-6%) SHY(-4%) TIP(-3%) | | | | | | | | Relative Volatility | (options are extremely cheap) | | | | | Market Trend Strength | -1.43% (StdDev 2.86%) | | Hourly BBV | 0 () | | Intraday Trend | 1.5% | | | | | |
|
| 5 Day Moving Average | $558.22(0.03%) | | 10 Day Moving Average | $561.42(-0.54%) | | 20 Day Moving Average | $555.32(0.55%) | | To recent high | -3.6% | | To recent low | 23.6% | | Market Cap | $59.204b | | | | | | |
Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |